| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |